Managed care
Michel S. Badin, MD PA
Michel S. Badin, MD PA was paid $1.74M by Medicaid between Jan 2018 and Dec 2024, across 50 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 36% of everything it billed.
33Billing provider infoMICHEL S. BADIN, MD PA
JERSEY CITY, NJ 07305
JERSEY CITY, NJ 07305
33aNPI1649344987assigned 11/20/2006
33bProvider typePreferred Provider Organization
28Total paid$1.74M
24GClaims144,698
24DCodes billed50
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Preferred Provider Organization providers in New Jersey
Rank by total paid#3 of 9
Median peer was paid$601K
This provider vs. median2.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 8,425 | $242K | |
| 2019 | 12,961 | $233K | |
| 2020 | 14,883 | $246K | |
| 2021 | 18,213 | $352K | |
| 2022 | 21,553 | $309K | |
| 2023 | 45,508 | $181K | |
| 2024incomplete | 23,155 | $175K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 36% | 30,102 | 16,171 | $625K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 13% | 6,828 | 4,674 | $221K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 7.2% | 11,084 | 4,447 | $124K |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 6.0% | 6,955 | 1,257 | $105K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 6.0% | 10,423 | 5,156 | $104K |
| J1756 | Injection, iron sucrose, 1 mg | 5.0% | 4,103 | 1,095 | $87K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 4.6% | 2,832 | 1,369 | $80K |
| 96367 | 4.1% | 4,796 | 1,910 | $70K | |
| 99223 | Prolong inpt eval add15 m | 2.3% | 1,358 | 1,217 | $40K |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 1.8% | 169 | 54 | $31K |
| 96415 | 1.7% | 2,703 | 1,293 | $29K | |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 1.5% | 1,864 | 428 | $26K |
38 more codes
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 6,916 | $17K |
| 99254 | <1% | 317 | $16K | |
| J3490 | Unclassified drugs | <1% | 9,223 | $14K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 384 | $13K |
| 96417 | <1% | 592 | $13K | |
| 99234 | <1% | 265 | $12K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 5,509 | $11K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,169 | $11K |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | <1% | 72 | $11K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,647 | $10K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 817 | $10K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,285 | $8K |
| J2780 | Injection, ranitidine hydrochloride, 25 mg | <1% | 196 | $8K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 121 | $6K |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 6,816 | $4K |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 7,669 | $4K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 174 | $3K |
| 99253 | <1% | 41 | $3K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 3,654 | $2K |
| 99242 | <1% | 162 | $2K | |
| 96401 | <1% | 108 | $2K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 3,767 | $2K |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,208 | $2K |
| 99245 | <1% | 13 | $1K | |
| J7070 | Infusion, d5w, 1000 cc | <1% | 628 | $1K |
| 99205 | Prolong outpt/office vis | <1% | 12 | $992.43 |
| 90756 | <1% | 68 | $875.27 | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 66 | $805.24 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 2,650 | $737.15 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 60 | $682.32 |
| 96523 | <1% | 946 | $566.73 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 321 | $300.22 |
| 90656 | <1% | 17 | $274.97 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 135 | $177.83 |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 49 | $57.54 |
| 36410 | <1% | 144 | $36.41 | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 248 | $25.30 |
| G0008 | Administration of influenza virus vaccine | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLEWIS, DANIELLE (MEDICAL BILLER)